The tech giant's new innovative products include ones poised to benefit from the pandemic-driven surge in the number of people working, playing, and socializing...
A charged-up 12-bagger, fading specialty retailer, and a hot overseas automaker pretty vulnerable right now.
Air travel demand is sagging again due to a surge in COVID-19 cases, but that doesn't mean investors need to avoid all airline stocks.
This coronavirus vaccine maker started the year at $4. It's since gained more than 2,000%.
Verizon's 5G wireless network goals continue to focus on large organizations... for now.
After a good earnings report, Wall Street remains upbeat on NIO's growth potential.
The automaker is quietly building a massive and lucrative software business.
For some investors, the answer is "yes."
The AI-driven data center and gaming businesses are firing on all cylinders.
The Oracle of Omaha and his investing lieutenants knew what they were doing in buying AbbVie, BMS, Merck, and Pfizer.